Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-037478

Chief Scientific Officer sold 21,790 shares at an average $21.64 ($471,437)

  • Chief Scientific Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Monahan Joseph Chief Scientific Officer 2021-06-01 Option exercise +50,000 107,132 D: show line 1 in the form
Monahan Joseph Chief Scientific Officer 2021-06-02 Sale −18,240 $21.50 $392,231 88,892 D: show line 2 in the form
Monahan Joseph Chief Scientific Officer 2021-06-02 Sale −3,550 $22.31 $79,205 85,342 D: show line 3 in the form
Open-market sales · 21,790 sh · avg $21.64 · $471,437

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Monahan Joseph Chief Scientific Officer 2021-06-01 Option exercise · Restricted Stock Units −50,000 0 D: show line 4 in the form
Loading xslF345X03/doc4.xml…